首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human IL17A Recombinant Antibody(Ixekizumab)

Anti-Human IL17A Recombinant Antibody(Ixekizumab)

产品编号

YR1008

别名

科研级 Ixekizumab ( 伊卡组单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Ixekizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Ixekizumab ( 伊卡组单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Ixekizumab
Catalog NumberYR1008
Molecular NameIxekizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG4 Kappa
FormulationPBS, pH7.5
BackgroundIxekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody.[5] The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.
CAS Number1143503-69-8
ApplicationWB, IP, IF, FuncS, FCM, Neut, ELISA
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
Molecular Weight146.16 kDa
TargetIL17A[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价